These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
207 related items for PubMed ID: 5332371
21. [Secretolytic effect of sobrelol and improvement of pulmonary ventilation in patients with chronic pulmonary tuberculosis associated with chronic bronchitis]. Bosisio E, Sergi M, Nunziante A, Baudin E. G Ital Mal Torace; 1971; 25(3):145-61. PubMed ID: 5143403 [No Abstract] [Full Text] [Related]
22. [Experiences with the mucolytic agent Bisolvon: its effect on sputum production]. Gürtler J. Praxis; 1965 Aug 12; 54(32):948-53. PubMed ID: 5320017 [No Abstract] [Full Text] [Related]
23. [Letosteine in chronic obstructive bronchopneumopathy]. Meroni P, Palmieri G, De Bartolo G, Barcellini W, Albrici A, Froldi M. Clin Ter; 1983 Apr 30; 105(2):109-18. PubMed ID: 6345052 [No Abstract] [Full Text] [Related]
24. [Experiences with the parenteral administration of a bronchosecretolytic agent, bromhexine]. Grundner H, Hoflehner G. Wien Med Wochenschr; 1970 Jul 25; 120(30):535-6. PubMed ID: 5513641 [No Abstract] [Full Text] [Related]
25. [Pediatric Asthma-Bisolvon suppositories in the treatment of asthmatic bronchitis and bronchial asthma in childhood]. Kessler H. Fortschr Med; 1972 Sep 28; 90(27):993-5. PubMed ID: 4653175 [No Abstract] [Full Text] [Related]
26. [Practical trials with Bisolvon, a new bronchial expectorant]. Kleine-Allekotte B. Hippokrates; 1965 Jul 15; 36(13):521-3. PubMed ID: 5319471 [No Abstract] [Full Text] [Related]
27. [Pulmonary volumetric changes caused by N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride]. Brignani F, Cavalli A, Fabbri M, Melica A. Minerva Med; 1969 Sep 19; 60(75):3545-8. PubMed ID: 5344814 [No Abstract] [Full Text] [Related]
28. [D1-sobrerol in the treatment of acute and chronic bronchopulmonary phlogoses]. Balzano E, De Gaetani G. Minerva Med; 1973 May 25; 64(37):1995-2002. PubMed ID: 4578344 [No Abstract] [Full Text] [Related]
29. [Evaluation of aerosol bronchodilators by ventilatory tests. Comparative study of isoproterenol and metaproterenol]. Bilodeau M, Roy JC. Union Med Can; 1968 Sep 25; 97(9):1182-90. PubMed ID: 4921609 [No Abstract] [Full Text] [Related]
32. [Long-term treatment of chronic bronchitis with Bisolvon. A clinical double-blind study on the effects of a new mucolytic agent studied in ambulant patients in the winter of 1968-1969]. Christensen F, Kjer J, Ryskjaer S, Arseth-Hansen P. Ugeskr Laeger; 1970 May 21; 132(21):978-82. PubMed ID: 4911647 [No Abstract] [Full Text] [Related]
33. [Treatment of the chronic bronchitic syndrome with Ozothine]. Nonhoff R. Med Monatsschr; 1967 Aug 21; 21(8):367-70. PubMed ID: 5597098 [No Abstract] [Full Text] [Related]
34. [Long-term treatment of the bronchitis syndrome with combinations of a secretolytic agent (Bisolvon-Linctus, Bisulvonamide, Bisolvonmycin)]. Görlach FW. Hippokrates; 1969 Nov 15; 40(21):850-3. PubMed ID: 5382635 [No Abstract] [Full Text] [Related]
35. [Effects of treatment with N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride in oral adminstration on bronchial secretions; cytological findings]. Lenzini L, Barnabè R. Minerva Med; 1969 Sep 22; 60(76):3580-2. PubMed ID: 5823754 [No Abstract] [Full Text] [Related]
36. Clinical trial with CO-1177: a preliminary report. Mbuyamba P. Int J Clin Pharmacol Res; 1986 Sep 22; 6(2):119-21. PubMed ID: 3522442 [Abstract] [Full Text] [Related]
37. Metaproterenol, a new bronchodilator:: comparison with isoproterenol. Pelz HH. Am J Med Sci; 1967 Mar 22; 253(3):321-4. PubMed ID: 6021691 [No Abstract] [Full Text] [Related]
38. [The secretolytic treatment of rhinopharyngitis sicca]. Uhlemann Bülow I, Millard J. Dtsch Med J; 1966 Jan 20; 17(2):47-8. PubMed ID: 5943587 [No Abstract] [Full Text] [Related]
39. [Experience with the new inhalation preparation H9b-HN]. Bamberg H. Med Welt; 1969 Nov 08; 45():2493-4. PubMed ID: 5371527 [No Abstract] [Full Text] [Related]
40. [Comparison of therapeutic effect of 2 application forms of a combination of N-cyclohexyl-N-methyl-(2-amino-3,5-dibrombenzyl)-ammonium-chloride and sulfanilamidopyrimidine. A widespread mutual test]. Oligschläger G. Arzneimittelforschung; 1969 Oct 08; 19(10):1710-7. PubMed ID: 5395373 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]